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Aeromedical Issues 
FORUM 
AEROMEDICAL ISSUES IN DL4BETIC A MATORS 
Robert T. Keegan 111 and Bascom K. Bradshaw 
ABSTRACT 
I 
Diabetes mellitus is a common disease that poses a serious health and safety threat to civilian aviators. Complications 
secondary to diabetes can be severe and result in sudden incapacitation. The Federal Aviation Administration (FAA) 
has developed regulabons for certifLrng aviators with diabetes, as well as guidelines for in-flight management of blood 
glucose levels. Advances in medical technology have led to treatments and countermeasures for diabetes that enable 
many individuals to engage in physically and mentally demanding activities. This paper presents a basic overview of 
the pathophysiology, diagnosis, and maaagement of diabetes mellitus in civil aviators. In addition, current FAA 
regulations for medid  certification and blood glucose management will be outlined. 
BACKGROUND 
In order to understand the hazard that diabetes poses to a 
pilot's health and flying safety, one must understand the 
nature of this condition. Diabetes is a metabolic condition 
that usually presents with symptoms of uncontrolled blood 
sugar, such as increased urination, persistent thirst, 
hquent urination at night, and weight loss (Braunstein, 
G.D., Friedman, T., Herman-Bonert, V., Peters, A.L., 
1997). A random blood sugar level greater than 200 mgldl 
usually confirms the diagnosis. Diabetes mellitus is a life- 
long disease that can lead to blindness, heart and blood 
vessel disease, strokes, kidney failure, amputations, nerve 
damage, and death. 
Diabetes is generally the result of the body's 
inability to produce enough insulin, resistance to insulin, or 
both (Braunstein et al., 1997). Insulin is a polypeptide 
hormone secreted by the islets of Langerhans, located in the 
pancreas. Its primary function is to regulate the metabolism 
of carbohydrates and fats, especially the conversion of 
glucose to glycogen. This conversion is what lowers the 
blood glucose level. In addition, insulin allows nutrients to 
enter the muscle were it can be stored and later used for 
energy. 
How does this process unfold during our daily 
consumption of food? Food is digested in the stomach and 
the intestines where carbohydrates are broken down in to 
sugar molecules, or glucose. At this point glucose is 
absorbed into the circulatory system, causing the blood 
glucose levels to rise. In response to elevated blood glucose 
levels, the pancreas releases insulin from beta cells. 
There are 18.2 million people in the United States, 
or 6.3% of the @tion, who have diabetes (American 
Diabetes Association, 2003). While an estimated 13 million 
have been diagnosed, unfortunately, 5.2 million people (or 
nearly onethird) are unaware that they have the disease 
(ADA, 2003). on xi mat el^ 2,200 people are diagnosed 
with diabetes each day. Almost 800,000 people will be 
diagnosed each year. Diabetes is the seventh leading cause 
of death and sixth-leading cause of death by disease in the 
United States (ADA, 2003). 
TYPE I DIABETES 
Diabetes is generally classified into two basic 
categories: type I and type 11. Type I diabetes, or insulin 
dependent diabetes, usually presents at a young age and is 
characterized by the inability of beta cells in the pancreas 
to produce adequate levels of insulin. Without the 
appropriate level of insulin in the bloodstream, glucose 
levels increase and cannot be converted into energy. After 
five to ten years, the beta cells of the pancreas are 
completely destroyed. The exact process leading to type I 
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diabetes mellitus is still not known. 
There are several indicators related to type I 
diabetes: increased thirst and urination do to the in-sed 
glucose levels in the bloodstream; weight loss, despite an 
increased appetite; and nausea, vomiting, abdominal pain, 
and fatigue. Type I symptoms are usually severe and occur 
rapidly. Type I diabetes accounts for three percent of all 
new cases of diabetes each year. The disease primarily 
affects children, with one new case per every 7,000 children 
per year. Initial presentation is less common among adults 
older than twenty  rakein in et al., 1997). 
Insulin injections and blood glucose monitoring 
are the mainstay of therapy for type I diabetes. Failure to 
follow this course of treatment can result in complications 
and a premature death. In addition, those with type I should 
maintain good health practices, such as a controlled diet 
. and physical exercise. 
TYPE I1 DIABETES 
Type II diabetes is known as noninsulindependent 
diabetes mellitus and adult-onset diabetes. It is thought to 
be the result of insulin resistance at the fat and muscle cell 
level. As a result of this resistance, insulin cannot be 
properly utilized to let glucose into cells to produce energy. 
This results in abnormal levels of glucose in the 
bloodstream and urine. Type 11 diabetes has several 
indicators: excessive thirst, frequent urination, fatigue, 
blurred vision, and slow healing of injuries. Lastly, 
individuals with type I1 diabetes suffer from an increased 
weight loss despite an amplification of appetite (Braunstein 
eta]., 1997). 
Family history is a risk factor in type I1 diabetes, 
which indicates that genetics play a large role in an 
individual's predisposition. Environmental factors, such as 
a sedentary lifestyle and poor diet, can elevate a person's 
risk for type 11 diabetes. Ethnicity, hypertension, and age 
are also risk factors. Approximately sixteen million people 
have type I1 diabetes and almost half of are unaware of 
their condition. Type II diabetes often goes undetected for 
many years because symptoms develop gradually without 
overt physical signs. 
Several treatments are available to treat type I1 
diabetes. Initial treatment generally consists of lifestyle 
modifications, such as weight control by strict diet and 
exercise. Most people diagnosed with type II diabetes are 
obese and have relatively inactive lifestyle habits. Type I1 
diabetes can also be treated with oral medications. Several 
types of oral hypoglycemics are available to treat type I1 
diabetes. One type increases insulin production; another 
decreases insulin resistance, while the last slows absorption 
of carbohydrates. 
An important complication of diabetes is 
hypoglycemia. It occurs when there is a low blood glucose 
level. Both type I and type I1 diabetics can suffer from 
hypoglycemia. The brain is dependent on a supply of 
glucose to function. When blood levels begin to fall the 
brain starts a series of physiological responses, which 
include cognitive impairment and decreased blood flow in 
the brain (Braunstein et al., 1997). 
Hypoglycemia can be separated into three 
categories: mild, moderate, and severe. Mild symptoms 
consist of nausea, apprehension, excessive sweating, 
i n d  heat rate, and trembling. Moderate hypoglycemia 
is characterized by mood changes, confusion, blurred 
vision, dizziness, and headache. Additional symptoms 
include weakness, poor coordination, fatigue, and impaued 
walking and talking. Severe hypoglycemia symptoms are 
the most devastating. Seizures, loss of consciousness, and 
coma can occur. Prolonged periods of severe hypoglycemia 
can lead to irreversible brain damage, heart problems, and 
even death (Braunstein et al., 1997). 
FAA REGULATIONS 
The Federal Aviation Administration (FAA) has 
several rules and regulations regarding airmen with 
diabetes. The FAA created a policy in 19% that allows 
insulin-treated applicants to receive a thirdclass medical 
certificate (Stephens,2OOO). Individuals granted this 
special issuance are restricted to flying within the United 
States. The medical certificate is only good for one year 
and requires close physician supervision. First and second- 
class license are not considered for certification although 
special issuance may be considered on a case-bycase basis. 
Applicants are only considered if they have a stable 
condition for six months on their current treatment. The 
applicant must not have any recurrent episodes of 
hypoglycemia in the past five years. The individual must 
also not have any episodes resulting in loss of 
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consciousness, seizure, or impaired cognitive function 
requiring medical intervention. Sudden incapacitation from 
hypoglycemia (hypoglycemia unawareness) within the 
preceding year is also disq-ng (The Federal Aviation 
Administration, 2003). Airmen must provide medical 
records recording any incidents or mishaps that were 
related to their condition. A complete medical examination 
should also be conducted. It is preferred that such an 
examination is conducted by a diabetes specialist. The 
examination includes measurements of glycated 
hemoglobin, which provides' a reference of diabetes 
management. Insulin dosage, diet, documented training on 
glucometer usage, and recognition and treatment of 
symptoms. Presence or absence of cerebrovascular, 
cardiovascular, peripheral vascular disease, or neuropathy 
should be documented. An eye speaahst should confirm 
the absence of clinically signrficant eye disease. Lastly, 
airmen over the age of forty must submit a report with ECG 
tracings of a maximal graded exercise stress test (FAA, 
2003). Airmen require evaluations every three months by 
their treating physician and have an annual physical 
requirement. 
Diabetic airmen that are certified to fly are 
required by the FAA to camy a recording glucose meter and 
10 gram portions of a rapidly absorbable glucose 
appropriate for the duration of a planned flight. Pilots are 
required to measure blood glucose levels several times, with 
the first interval thirty minutes prior to takeoff. The 
prefight blood glucose should not be lower than 10 mgldl. 
If blood glucose falls below this level, the airman must 
ingest no less then a 10 gram glucose snack and retest 
thirty minutes later. The process must be repeated if the 
blood glucose level remains below 100 mgldl. If it exceeds 
300mgld1, the flight must be cancelled. The airman must 
maintain a safe level of 100 to 300 mgldl to takeoff. In 
addition to preflight requirements, an airman must monitor 
blood glucose level one hour into flight and each 
consecutive hour. This process ensures that the glucose 
level is between the recommended levels. Ifthe person falls 
below 100 mgldl, the pilot must ingest a 20 gram glucose 
snack and retest one hour later. If levels are above 
300mg/dl, the individuals must land at the closest suitable 
airport until levels can be controlled. If an airman cannot 
Aeromedical Issues 
check his or her glucose level due to adverse conditions, the 
airman must ingest 10 gram glucose snack and recheck one 
hour later. If airmen cannot make a second reading one 
hour later helshe must ingest 20 gram glucose snack and 
land at the closest suitable airport until a proper blood 
glucose level can be obtained. Lastly, airmen must check 
levels one half hour prior to landing (FAA, 2003). 
FAA regulations concerning diabetes treated with 
oral medications are very similar b idindependent 
airmen (FAA, 2003). Type I1 diabetic airmen treated with 
oral medications are only required to have an annual 
physical. An airman should report changes in medication 
dosage or side effects. Individuals on oral hypoglycemics 
are also restricted to a class-three medical certification. 
Pilots, who can control their diabetes with diet and 
exercise, are eligible for all classes of medical certification 
(FAA, 2003). Certification is dependent on documented 
evidence of no associated disq-ng conditions, such as 
cardiovascular, neurological, renal, or eye disease. Special 
exams are not required unless it is indicated by the 
airman's clinical history or examination. 
AEROMEDICAL SAFETY ISSUES 
Type I and type II diabetic airmen must overcome 
several obstacles in order to fly. The FAA requirement to 
monitor blood glucose while inflight provides a potentially 
dangerous inflight distraction. A pdot must constantly veer 
their attention away from flying in order to monitor their 
blood glucose level. This situation greatly reduces 
situational awaren-ess and can lead to an increase in pilot 
error during critical phases of flight. One example 
commonly given is flying under adverse weather 
conditions. If an airman is unable to monitor glucose levels 
for two hours, the FAA requires the pilot to land at the 
closest suitable airport. Diabetic pilots trying to meet this 
demand in an already dangerous flying environment can 
lead to high stress levels potentially leading to an insulin 
reaction. Insulin reactions are caused by an imbalance 
between medication and diet leading to a drop in the blood 
glucose level. A pilot's ability to control an aircraft may be 
impaired because of the resulting hypoglycemia. 
Complacency is another threat to flying safety 
among diabetic airmen. Pilots who have flown with this 
condition for several years may fail to comply with blood 
JAAER, Winter 2004 Page 17 
3
Keegan and Bradshaw: Aeromedical Issues in Diabetic Aviators
Published by Scholarly Commons, 2004
Aeromedical Issues 
glucose monitoring requirements. This could lead to 
abnormally high or low blood glucose levels impairing the 
pilot's ability to fly safely. 
Pilot education is the most important preventive 
measure. All airmen should be educated to recognize the 
symptoms and risk facton of diabetes. This is especially 
important because it is estimated that eight million people 
in the United States have undiagnosed diabetes. Proper 
education can reduce the incidence of hypoglycemic 
episodes in unrecognized diabetics and provide airmen with 
the appropriate mourcek to help mitigate the effects of this 
condition. 
Several technological advances in diagnosing and 
treating diabetes have in- the safety of flying with 
this condition. Compact blood glucose meters, the size of a 
stopwatch, allow individuals to acquire accurate blood 
glucose levels in less than thirty seconds. Proactive 
regulations by the FAA for monitoring blood glucose levels 
before and during flights have helped decrease the amount 
of mishaps due to hyper- and hypoglycemic reactions. 
Medications have also made several advances over the last 
few years. Four waiverable oral medications are available 
to airmen after proper medical evaluation. This variety 
allows an individual with type I1 diabetes a better chance of 
finding a medication that works for them. 
With the advances in medication and testing 
equipment that are currently available, future mishaps due 
to insulin reactions inflight can be avoided. Four hundred 
airmen are currently flying with type I diabetes (FAA, 
2003). With the large number of newly diagnosed diabetics 
each year, the number of airmen flying with diabetes will 
steadily increase and the FAA will continue to mode  its 
regulations in order to optimize flying safety. .+ 
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